StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) income statement

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.71−0.07 (-1.98%)

Close on Nov 19, 2026Market cap $465.02MP/E –Yield –

Aquestive Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
67.0%
Operating margin
-97.5%
Net margin
-144.6%
Return on equity, FY2025
178.6%

Financial strength

Current ratio
7.19
Debt to equity
-0.90
Debt to assets
38.4%
Cash to current liabilities
597.7%

Valuation

P/E ratio
–
Price to sales
8.60
Price to book
–
Dividend yield
–

See a number that looks wrong?